Paeonol prevents migration and invasion, and promotes apoptosis of cervical cancer cells by inhibiting 5‑lipoxygenase

Sheng,Shao-Qin; Yu,Lei-Yuan; Zhou,Xian-Wei; Pan,Hong-Yi; Hu,Feng-Ying; Liu,Jia-Li

doi:10.3892/mmr.2021.12040

Paeonol prevents migration and invasion, and promotes apoptosis of cervical cancer cells by inhibiting 5‑lipoxygenase

Authors:
- Shao-Qin Sheng
- Lei-Yuan Yu
- Xian-Wei Zhou
- Hong-Yi Pan
- Feng-Ying Hu
- Jia-Li Liu
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310005, P.R. China, Second Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310005, P.R. China, Third Clinical Medical College, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang 310005, P.R. China
Published online on: March 26, 2021 https://doi.org/10.3892/mmr.2021.12040
Article Number: 401
Copyright: © Sheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer is a common public health issue with high morbidity worldwide. Paeonol (Pae) has been recognized as a traditional Chinese medicine used for the treatment of various cancer types. However, whether Pae could exert a protective effect on cervical cancer remains to be investigated. The aim of the present study was to explore the role of Pae in cervical cancer cells and identify the potential mechanism. Cell Counting Kit‑8 and colony‑formation assays were conducted to test the proliferation of HeLa cells. Additionally, wound healing and transwell assays were used to detect the migratory and invasive abilities of cells. The plasmid that overexpressed 5‑lipoxygenase (5‑LO) or control vector was constructed and transfected into the cells. Subsequently, flow cytometry was used to monitor the apoptotic rate of cells. The expression levels of apoptosis‑associated proteins and 5‑LO were detected using western blot analysis. Reverse transcription‑quantitative PCR analysis detected the expression of 5‑LO. Pae inhibited the proliferation, invasion and migration of HeLa cells, promoted cell apoptosis and downregulated the expression of 5‑LO. Overexpression of 5‑LO, however, attenuated these effects. Thus, Pae could inhibit the proliferation, migration and invasion, as well as promote apoptosis of HeLa cells by regulating the expression of 5‑LO.

View Figures

View References

1	Wei J and Wang Y, Shi K and Wang Y: Identification of core prognosis-related candidate genes in cervical cancer via integrated bioinformatical analysis. Biomed Res Int. 2020:89592102020. View Article : Google Scholar : PubMed/NCBI
2	Wei H, Wang XW, Chen KM, Ling SR and Yi CJ: Analysis of gene mutation associated with tyrosine kinase inhibitor sensitivity of epidermal growth factor receptor in cervical cancer patients. Eur Rev Med Pharmacol Sci. 22:6280–6287. 2018.PubMed/NCBI
3	Cheng CS, Chen JX, Tang J, Geng YW, Zheng L, Lv LL, Chen LY and Chen Z: Paeonol inhibits pancreatic cancer cell migration and invasion through the inhibition of TGF-β1/smad signaling and epithelial-mesenchymal-transition. Cancer Manag Res. 12:641–651. 2020. View Article : Google Scholar : PubMed/NCBI
4	Mohamed MZ, Morsy MA, Mohamed HH and Hafez HM: Paeonol protects against testicular ischaemia-reperfusion injury in rats through inhibition of oxidative stress and inflammation. Andrologia. 52:e135992020. View Article : Google Scholar : PubMed/NCBI
5	Gao L, Wang Z, Lu D, Huang J, Liu J and Hong L: Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis. 10:6092019. View Article : Google Scholar : PubMed/NCBI
6	Zhou J, Liu Q, Qian R, Liu S, Hu W and Liu Z: Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-κB pathway. Acta histochemica. 122:1514552020. View Article : Google Scholar : PubMed/NCBI
7	Fu J, Yu L, Luo J, Huo R and Zhu B: Paeonol induces the apoptosis of the SGC7901 gastric cancer cell line by downregulating ERBB2 and inhibiting the NF-κB signaling pathway. Int J Mol Med. 42:1473–1483. 2018.PubMed/NCBI
8	Saahene RO, Wang J, Wang ML, Agbo E and Pang D: The antitumor mechanism of paeonol on CXCL4/CXCR3-B signals in breast cancer through induction of tumor cell apoptosis. Cancer Biother Radiopharm. 33:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
9	Moore GY and Pidgeon GP: Cross-talk between cancer cells and the tumour microenvironment: The role of the 5-Lipoxygenase pathway. Int J Mol Sci. 18:2362017. View Article : Google Scholar
10	Mahboubi-Rabbani M and Zarghi A: Lipoxygenase inhibitors as cancer chemopreventives: Discovery, recent developments, and future perspectives. Curr Med Chem. 2019. View Article : Google Scholar : PubMed/NCBI
11	Monga J, Subramani D, Bharathan A and Ghosh J: Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. Sci Rep. 10:66492020. View Article : Google Scholar : PubMed/NCBI
12	Costa H, Touma J, Davoudi B, Benard M, Sauer T, Geisler J, Vetvik K, Rahbar A and Soderberg-Naucler C: Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer. J Cancer Res Clin Oncol. 145:2083–2095. 2019. View Article : Google Scholar : PubMed/NCBI
13	Go JH, Wei JD, Park JI, Ahn KS and Kim JH: Wogonin suppresses the LPSenhanced invasiveness of MDAMB231 breast cancer cells by inhibiting the 5LO/BLT2 cascade. Int J Mol Med. 42:1899–1908, 20180. PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, et al: Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol. 124:92–97. 2012. View Article : Google Scholar : PubMed/NCBI
16	Aishanjiang A, Rouzi N, Jiao Z, Wang L, Wusainahong K, Wumanjiang N, Musha M and Niyazi M: MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting FOXO1. Eur Rev Med Pharmacol Sci. 22:2253–2260. 2018.PubMed/NCBI
17	Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment. ScientificWorldJournal. 2014:1780752014. View Article : Google Scholar : PubMed/NCBI
18	Meng X, Chu Y, Pan Y, Han L, Meng Z and Wang X: Preoperative neoadjuvant chemotherapy combined with radical surgery in cervical cancer. J BUON. 25:125–131. 2020.PubMed/NCBI
19	Al-Taher AY, Morsy MA, Rifaai RA, Zenhom NM and Abdel-Gaber SA: Paeonol attenuates methotrexate-induced cardiac toxicity in rats by inhibiting oxidative stress and suppressing TLR4-Induced NF-κB inflammatory pathway. Mediators Inflamm. 2020:86410262020. View Article : Google Scholar : PubMed/NCBI
20	Jin X, Wang J, Xia ZM, Shang CH, Chao QL, Liu YR, Fan HY, Chen DQ, Qiu F and Zhao F: Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking MAPK/ERK/p38 signaling pathway. Inflammation. 39:434–446. 2016. View Article : Google Scholar : PubMed/NCBI
21	Hafez HM, Morsy MA, Mohamed MZ and Zenhom NM: Mechanisms underlying gastroprotective effect of paeonol against indomethacin-induced ulcer in rats. Hum Exp Toxicol. 38:510–518. 2019. View Article : Google Scholar : PubMed/NCBI
22	Li H, Song F, Duan LR, Sheng JJ, Xie YH, Yang Q, Chen Y, Dong QQ, Zhang BL and Wang SW: Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway. Sci Rep. 6:236932016. View Article : Google Scholar : PubMed/NCBI
23	Cheng CS, Chen JX, Tang J, Geng YW, Zheng L, Lv LL, Chen LY and Chen Z: Paeonol inhibits pancreatic cancer cell migration and invasion through the inhibition of TGF-beta1/smad signaling and epithelial-mesenchymal-transition. Cancer Manag Res. 12:641–651. 2020. View Article : Google Scholar : PubMed/NCBI
24	Liu X, Xu Q, Mei L, Lei H, Wen Q, Miao J, Huang H, Chen D, Du S, Zhang S, et al: Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats. Int Immunopharmacol. 61:169–177. 2018. View Article : Google Scholar : PubMed/NCBI
25	Mei L, He M, Zhang C, Miao J, Wen Q, Liu X, Xu Q, Ye S, Ye P, Huang H, et al: Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p. Sci Rep. 9:193702019. View Article : Google Scholar : PubMed/NCBI
26	Lyu ZK, Li CL, Jin Y, Liu YZ, Zhang X, Zhang F, Ning LN, Liang ES, Ma M, Gao W, et al: Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP2 and MMP9. Mol Med Rep. 16:7513–7519. 2017. View Article : Google Scholar : PubMed/NCBI
27	Bai CY, Zhang JY, Shi TW, Bai YQ, Wu BL, Du ZP, Wu ZY, Xu XE, Wang SH, Wu JY, et al: Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma. Oncol Lett. 15:9353–9360. 2018.PubMed/NCBI
28	Kummer NT, Nowicki TS, Azzi JP, Reyes I, Iacob C, Xie S, Swati I, Darzynkiewicz Z, Gotlinger KH, Suslina N, et al: Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. J Cell Biochem. 113:1998–2008. 2012. View Article : Google Scholar : PubMed/NCBI